Publications and Research Trials:
1 Healthcare Worker Seroconversion in SARS outbreak
P Chow, Eng EO, HK Tan, Kw Ong, BK Sil, M Teo, T Ng, KC Soo
Emerging Infectious Diseases Journal Feb 2004; 10:2
2 Bevacizumab and rapamycin inhibit tumor growth in peritoneal model of human ovarian cancer
Huynh H, M Teo, Soo KC
Mol Cancer Ther. 2007 Nov; 6(11):2959-66
3 Preoperative radiation with concurrent chemotherapy for resectable rectal cancer: long-term follow-up results of a dose escalation study
M Teo, Ridgway PF, Wiltshire KL, Ward IG, Swallow CJ, Oza AM, Cummings B, Pond GR, Catton P, Kim J, Ringash J, Wong R, Siu L, Moore M, Brierley J
Canadian Journal of Surgery (suppl) 2008: 51: pp 38
4 First Somatic Mutation of E2F1 in a Critical Binding Residue Discovered in Well-differentiated Papillary Mesothelioma of the Peritoneum
W Yu, W Chan-On, M Teo, Ong CK, I Cutcutache, GE Allen, B Wong, M Swe Swe, Lim KH, PM Voorhoeve, S Rozen, Soo KC, P Tan, Teh BT.
Genome Biology Sept 2011; 12(9)
5 Cancer Trends and Incidences in Singapore
M Teo, KC Soo
Japanese Journal of Oncology (JJCO Manuscript JJCO-12-0178.RI)DOI: 10.1093/jjco/hys230
6 Cutaneous vs Non-Cutaneous Angiosarcoma: Clinicopathologic Features and Treatment Outcomes in 60 Patients At a Single Asian Cancer Centre.
F Mohamad, WS Ong, M Lee, R Jeevan, ZC Ho, A N H Sairi, LT Soh, D Poon, YH Teh, F Chin, M Teo, R Quek.
Oncology 2013 85 (3): 182-90
7 Quality of Life After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: An Asian Perspective
Tan WJ, Wong JF, Chia CS, Tan GH, Soo KC, M Teo
Ann Surg Oncol 2013, 4219-23 20(13)
8 The influence of Primary Site on outcomes in leiomyosarcoma: a review of clinicopathologic differences between uterine and extrauterine disease
Farid M, Ong WS, Tan MH, Foo LS, Lim YK, Chia WK, Soh LT, Poon D, Lee MJ, Ho ZC, Jeevan R, Chin F, M Teo, Quek R
American Journal of Clinical Oncology, 2013 Aug;36(4):368-74. Doi: 10.1097/COC.0b013e318248dbf4 PMID: 22772425
9 Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Asian Patients: 100 Consecutive Patients in a Single Institution
M Teo, G Tan, CK Tham, C, KC Soo
Annals of Surgical Oncology 2013 Sep;20(9):2968-74. doi: 10.1245/s10434-013-2947-0 Epub 2013 Mar 17
10 Peri-operative morbidity and Quality of Life Outcomes following Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Asian Patients
W Tan, C Chia, G Tan, J Wong, M Teo
Annals of Surgical Oncology. Sept 2013
11 The influence of primary site on outcomes in leiomyosarcoma: a review of clinicopathologic differences between uterine and extrauterine disease.
Farid M, Ong WS, Tan MH, Foo LS, Lim YK, Chia WK, Soh LT, Poon D, Lee MJ, Ho ZC, Jeevan R, Chin F, M Teo, Quek R.
Am J Clin Oncol. 2013 Aug;36(4):368-74.
12 Validation of the MSKCC Gastrointestinal Stromal Tumor Nomogram and comparison with current prognostication systems: single institution experience with 289 Asian patients
Chok AY, B Goh, Koh YX, Lye WK, John C. A, R Quek, M Teo, P Chow, Ong HS, A Chung, Wong WK
Ann Surg Oncol. 2015 Oct; 22(11): 3597-605. doi: 10.1245/s10434-015-4400-z. Epub 2015 Feb 5.
13 Whole exome sequencing of breast cancer, malignant peripheral nerve sheath tumour (MPNST) and neurofibroma from a patient with neurofibromatosis type 1 (NF1)
J R McPherson, CK Ong, C CY Ng, V Rajasegaran, HL Heng, W SS Yu, B KT Tan, P Madhukumar, M Teo, J YY Ngeow, AA Thike, S Rozen, PH Tan, A SG Lee, BT Teh, YS Yap
Cancer Med. 2015 Oct 3. doi: 10.1002/cam4.551. [Epub ahead of print]
14 National Cancer Center Singapore: the way forward
M Teo, Soo KC
2016 Future Medicine 10.2217/fon.15.331
15 Blood neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio are independent prognostic factors for surgically-resected gastrointestinal stromal tumors
B Goh, AY Chok, J. C. Allen, R Quek, M Teo, P Chow, A Chung, HS Ong, WK Wong
Surgery. 2015 Dec 10. pii: S0039-6060(15)00892-2. [Epub ahead of print]
16 Two rare cases of appendiceal collision tumours involving an appendiceal mucinous neoplasm and carcinoid
Tan HL, G Tan, M Teo
BMJ Case Reports 2016;Doi: 10.1136/bcr-2015-213938
17 Does Early Postoperative Intraperitoneal Chemotherapy (EPIC) for Patients treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) make a different?
G Tan, Ong WS, C Chia, Tham CK, Soo KC, M Teo
Int J Hyperthermia. 2016 Feb 10:1-8.
18 Prospective quality of life study for colorectal cancer patients with peritoneal carcinomatosis undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
C Chia, G Tan, C Lim, Soo KC, M Teo
Annals of Surgical Oncology 2016 Mar 25 (Epub ahead of print) Pp 1-9
19 Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of uterine leiomyosarcoma with peritoneal sarcomatosis: a case report and review of the literature
L. Chen, M Teo
Journal of cases in Obstetrics & Gynaecology (Accepted)
20 Acute Kidney Injury In Ovarian Cancer Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
E Sin, C Chia, C Lim, G Tan, Soo KC, M Teo
Int Journal of Hyperthermia (Accepted)